Franklin Genomic Advancements Etf Analysis
| HELX Etf | USD 27.27 0.05 0.18% |
Franklin Genomic Advancements is overvalued with Real Value of 24.81 and Hype Value of 27.27. The main objective of Franklin Genomic etf analysis is to determine its intrinsic value, which is an estimate of what Franklin Genomic Advancements is worth, separate from its market price. There are two main types of Franklin Etf analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic stability of Franklin Genomic Advancements. On the other hand, technical analysis, focuses on the price and volume data of Franklin Etf to identify patterns and trends that may indicate its future price movements.
The Franklin Genomic etf is traded in the USA on BATS Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Franklin | Build AI portfolio with Franklin Etf |
Franklin Etf Analysis Notes
Franklin Genomic is is formed as Regulated Investment Company in the United States. ETF is managed and operated by Franklin Templeton Services, LLC. The fund has 68 constituents across multiple sectors and instustries. The fund charges 0.5 percent management fee with a total expences of 0.5 percent of total asset. The fund retains 98.96% of assets under management (AUM) in equities. Under normal market conditions, the fund invests at least 80 percent of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. Franklin Genomic is traded on BATS Exchange in the United States. To learn more about Franklin Genomic Advancements call the company at NA.Sector Exposure
Franklin Genomic Advancements constituents include assets from different sectors. As a result, investing in Franklin Genomic lets you gain exposure to equities across multiple sectors, sub-sectors, or industries. This can reduce the risk of holding a single asset or a fund not diversified across different sectors or industries. Typically, investors would invest in Franklin Genomic because they prefer to avoid the increased volatility of non-sector ETFs.
Different industry classifications and sub-sectors that are found among Franklin Genomic's constituents divide the investing landscape into groups of entities that employ similar trades or provide related services. Combining these segments enables in-depth research of market dynamics to see which parts of the economy are growing or fading. In addition, sector investments offer targeted exposure to these segments, giving investors a wide variety of options to enhance their portfolios' asset allocations and adapt to market volatility.
Currency Exposure
Franklin Genomic Advancements manages assets traded in foreign countries, and the goal of international investors is to ensure that the increase in value from foreign constituents of Franklin Genomic will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, investors should be aware of the risk associated with depending on the development of foreign currencies.
Franklin Genomic Adv Investment Alerts
| Franklin Genomic Adv generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Trading Advice - news.stocktradersdaily.com | |
| Franklin Genomic Adv created five year return of -2.0% | |
| This fund retains 98.96% of its assets under management (AUM) in equities |
Franklin Genomic Thematic Classifications
In addition to having Franklin Genomic etf in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Theme ETFsUSA ETFs from Theme clasification | |
| Strategy ETFsUSA ETFs from Strategy clasification |
Management Efficiency
Franklin Genomic's management efficiency ratios could be used to measure how well Franklin Genomic manages its routine affairs as well as how well it operates its assets and liabilities.The decision-making processes within Franklin Genomic are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Returns 3 Y (3.24) | Returns 5 Y (2.22) | Returns 1 Y (13.16) | Total Assets 10.9 M | Returns YTD (5.48) |
Top Franklin Genomic Advancements Etf Constituents
| MEDP | Medpace Holdings | Stock | |
| VRTX | Vertex Pharmaceuticals | Stock | |
| VEEV | Veeva Systems Class | Stock | |
| TXG | 10X Genomics | Stock | |
| TMO | Thermo Fisher Scientific | Stock | |
| TDOC | Teladoc | Stock | |
| RGEN | Repligen | Stock | |
| REGN | Regeneron Pharmaceuticals | Stock | |
| QURE | Uniqure NV | Stock | |
| QGEN | Qiagen NV | Stock | |
| QDEL | Quidel | Stock | |
| NTRA | Natera Inc | Stock | |
| NTLA | Intellia Therapeutics | Stock | |
| MRNA | Moderna | Stock | |
| A | Agilent Technologies | Stock | |
| IQV | IQVIA Holdings | Stock | |
| ILMN | Illumina | Stock | |
| GH | Guardant Health | Stock | |
| EDIT | Editas Medicine | Stock | |
| DHR | Danaher | Stock | |
| CTVA | Corteva | Stock | |
| CRSP | Crispr Therapeutics AG | Stock | |
| BRKR | Bruker | Stock | |
| BIO | Bio Rad Laboratories | Stock | |
| AVTR | Avantor | Stock |
Technical Drivers
As of the 21st of June, Franklin Genomic shows the Standard Deviation of 2.08, coefficient of variation of (6,888), and Mean Deviation of 1.49. Franklin Genomic Adv technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the entity's future prices.Franklin Genomic Adv Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Kaufman Adaptive Moving Average allows the user to define Franklin Genomic Adv range across which they want the smoothing.
Franklin Genomic Adv Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Franklin Genomic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Franklin Genomic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Franklin Genomic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Transier William L over a year ago Acquisition by Transier William L of 1843 shares of Franklin Genomic subject to Rule 16b-3 |
Franklin Genomic Outstanding Bonds
Franklin Genomic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Franklin Genomic Adv uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Franklin bonds can be classified according to their maturity, which is the date when Franklin Genomic Advancements has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Franklin Genomic Predictive Daily Indicators
Franklin Genomic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Franklin Genomic etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Franklin Genomic Forecast Models
Franklin Genomic's time-series forecasting models are one of many Franklin Genomic's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Franklin Genomic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Franklin Etf Analysis
Etf analysis is the technique used by a trader or investor to examine and evaluate how Franklin Genomic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Franklin shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as Franklin Genomic. By using and applying Franklin Etf analysis, traders can create a robust methodology for identifying Franklin entry and exit points for their positions.
Under normal market conditions, the fund invests at least 80 percent of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. Franklin Genomic is traded on BATS Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our etf analysis tools, you can find out how much better you can do when adding Franklin Genomic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Franklin Genomic Advancements. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.